Authors: El-Sadr, WM Perlman, DC Denning, E Matts, JP Cohn, DL

Citation: Wm. El-sadr et al., A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: Differences in study outcomes, CLIN INF D, 32(4), 2001, pp. 623-632

Authors: Buchwald, H Boen, JR Nguyen, PA Williams, SE Matts, JP

Citation: H. Buchwald et al., Plasma lipids and cardiovascular risk: a POSCH report, ATHEROSCLER, 154(1), 2001, pp. 221-227

Authors: Gordin, F Chaisson, RE Matts, JP Miller, C Garcia, MD Hafner, R Valdespino, JL Coberly, J Schechter, M Klukowicz, AJ Barry, MA O'Brien, RJ

Citation: F. Gordin et al., Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons - An international randomized trial, J AM MED A, 283(11), 2000, pp. 1445-1450

Authors: El-Sadr, WM Burman, WJ Grant, LB Matts, JP Hafner, R Crane, L Zeh, D Gallagher, B Mannheimer, SB Martinez, A Gordin, F

Citation: Wm. El-sadr et al., Discontinuation of prophylaxis against Mycobacterium avium complex diseasein HIV-infected patients who have a response to antiretroviral therapy., N ENG J MED, 342(15), 2000, pp. 1085-1092

Authors: Telzak, EE Chirgwin, KD Nelson, ET Matts, JP Sepkowitz, KA Benson, CA Perlman, DC El-Sadr, WM

Citation: Ee. Telzak et al., Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens, INT J TUBE, 3(4), 1999, pp. 337-343